Active Pharmaceutical Ingredients Global Market Report 2024

Description

Active Pharmaceutical Ingredients Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on active pharmaceutical ingredients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for active pharmaceutical ingredients? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The active pharmaceutical ingredients market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Innovative APIs (Active Pharmaceutical Ingredient); Generic APIs (Active Pharmaceutical Ingredient)
2) By Manufacturer: Captive Manufacturers; Merchant Manufacturers
3) By Type Of Drug: Prescription Drugs; Over-The-Counter Drugs
4) By Therapeutic Application: Communicable Diseases; Oncology; Diabetes; Cardiovascular Disease; Pain Management; Respiratory Diseases; Other Therapeutic Applications
Companies Mentioned: Albemarle Corporation; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Limited; AbbVie Inc.; Teva Pharmaceutical Industries Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

An active pharmaceutical ingredient (API) is a crucial component or substance utilized in the production of a finished pharmaceutical product (FPP). It is specifically designed to exhibit pharmacological action or directly impact the treatment, mitigation, cure, or prevention of diseases. APIs also play a role in restoring, correcting, or modifying human physiological processes.

There are two main types of active pharmaceutical ingredients such as innovative APIs and generic APIs. Innovative APIs are associated with drugs containing active ingredients or combinations that have not been previously approved. These are often used to offer unique treatments for conditions lacking effective existing remedies. Manufacturers of APIs can be categorized as captive manufacturers and merchant manufacturers. The synthesis types of APIs include synthetic APIs and biotech APIs. These ingredients find applications in both prescription and over-the-counter drugs, targeting therapeutic areas such as communicable diseases, oncology, diabetes, cardiovascular disease, pain management, respiratory diseases, and others.

The active pharmaceutical ingredients market research report is one of a series of new reports from The Business Research Company that provides active pharmaceutical ingredients market statistics, including active pharmaceutical ingredients industry global market size, regional shares, competitors with an active pharmaceutical ingredients market share, detailed active pharmaceutical ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the active pharmaceutical ingredients industry. These active pharmaceutical ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $218.45 billion in 2023 to $233.55 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The historical growth in the active pharmaceutical ingredient (API) market can be attributed to several factors. This includes advancements in drug development, the expansion of the generic drug market, the globalization of pharmaceutical manufacturing, regulatory initiatives aimed at ensuring drug safety, the increased prominence of contract manufacturing organizations (CMOs), a focus on precision medicine, the emergence of biopharmaceuticals, and the impact of global pandemics and health threats. These factors collectively contributed to the development and evolution of the API industry during the historical period.

The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $305.2 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The anticipated growth in the forecast period for the active pharmaceutical ingredient (API) market can be attributed to various factors. These include the continuous increase in healthcare expenditure, a growing emphasis on rare diseases, the expansion of the biosimilars market, advancements in green chemistry practices, a focus on continuous manufacturing processes, regulatory support for innovation, the globalization of clinical trials, and an increased emphasis on sustainable and ethical practices. Major trends expected in the forecast period include the digitalization of drug development processes, investments in advanced manufacturing technologies, the production of APIs for rare diseases and orphan drugs, heightened regulatory scrutiny on quality, API serialization and traceability, and the continued growth of biopharmaceuticals and biotechnology products.

The expanding prevalence of chronic diseases is anticipated to be a driving factor for the growth of the active pharmaceutical ingredients (API) market. Chronic diseases, persisting for three months or more and often worsening over time, encompass conditions like cancer, heart disease, stroke, diabetes, and arthritis. APIs are integral to high-quality medications addressing various illnesses such as oncology, cardiology, neurology, and orthopedics. For instance, the International Diabetes Federation predicts a significant rise in diabetes cases to 578 million by 2030 and 700 million by 2045, with nearly half of diabetes-related deaths occurring in adults under 60, making it a top 10 cause of mortality. Hence, the escalating incidence of chronic diseases is expected to propel growth in the API market.

The escalating investment in research and development (R&D) is poised to drive the growth trajectory of the active pharmaceutical ingredients market. R&D investment involves allocating resources-financial, human, and technological-toward activities that generate new knowledge, innovate products, services, or processes, and enhance existing offerings. This investment significantly influences API development by fostering innovation, elevating product quality, and propelling advancements in the pharmaceutical sector. Entities like biopharmaceutical companies and government agencies channel resources into R&D to create innovative APIs and formulations, aiming to improve treatment outcomes and address unmet medical needs. Notably, in September 2023, the National Center for Science and Engineering Statistics reported a 13.6% increase in federal agency commitments for R&D in FY 2021, reaching an all-time high of $190.2 billion. Therefore, the escalating investment in R&D is a key driver for the active pharmaceutical ingredients market.

Technological advancements represent a pivotal trend gaining traction within the active pharmaceutical ingredients market. Leading market players are directing efforts toward implementing innovative technologies and methods for optimized API production. Techniques like continuous flow chemistry, advancements in lyophilization, powder handling, and process control are focal points for major companies aiming to maintain their market standing. A notable example involves the collaboration between NovAliX, ALYSOPHIL SAS, De Dietrich Process Systems, and Bruker in May 2022. This partnership introduced a groundbreaking approach to API production through the PIPAc (Production Intelligente de Principes Actifs) project. PIPAc aims to revolutionize API manufacturing by minimizing complex supply chains in pharmaceutical production and developing rapid-response mobile API production units for global deployment. Leveraging cutting-edge synthesis, continuous flow chemistry, in-flow analysis, and artificial intelligence, PIPAc seeks to create next-generation, autonomous, and optimized units.

Leading firms within the active pharmaceutical ingredients (API) sector are concentrating on the introduction of pioneering solutions, like Capsugel Enprotect, aimed at driving their market revenues. An innovative API solution represents an advanced pharmaceutical compound serving as the biologically active element in drug products. For example, in November 2022, Lonza Group AG unveiled Capsugel Enprotect, a groundbreaking capsule solution designed to transport acid-sensitive active pharmaceutical ingredients to the intestine. This coating-free capsule, a first of its kind, expedites drug development timelines by simplifying the manufacturing process, as it remains intact during stomach transit and releases its contents solely in the intestine. This innovative delivery method is tailored for use with small molecules, proteins, peptides, RNA-based medicines, and even aids in delivering living biotherapeutic products-an innovative class of medical interventions.

In June 2021, Aceto, a US-based supplier specializing in health sciences and high-tech markets, acquired Cascade Chemistry for an undisclosed sum. This strategic acquisition is anticipated to enhance Aceto's ability to support clients across the drug development continuum and grant easier access to expanded North American manufacturing capabilities, particularly concerning APIs and advanced intermediates. Cascade Chemistry, a US-based contract development and manufacturing organization (CDMO) renowned for manufacturing active pharmaceutical ingredients, aligns with Aceto's vision for growth and market diversification.

Major companies operating in the active pharmaceutical ingredients market report are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF Corporation, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Sun Pharmaceutical Industries Ltd., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline plc, Godrej Consumer Products, Roche Holding AG, Daiichi Sankyo Inc., Catalent Inc.

North America was the largest region in the active pharmaceutical ingredients market share in 2023. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The active pharmaceutical ingredient market consists of sales of active pharmaceutical ingredients that are used in final pharmaceutical products such as drug products (tablet, pill, cream, or injectable) to deliver a desired effect. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12417

1. Executive Summary

2. Active Pharmaceutical Ingredients Market Characteristics

3. Active Pharmaceutical Ingredients Market Trends And Strategies

4. Active Pharmaceutical Ingredients Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Active Pharmaceutical Ingredients Market Size and Growth

5.1. Global Active Pharmaceutical Ingredients Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Active Pharmaceutical Ingredients Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Active Pharmaceutical Ingredients Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Active Pharmaceutical Ingredients Market Segmentation

6.1. Global Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Innovative APIs (Active Pharmaceutical Ingredient)
Generic APIs (Active Pharmaceutical Ingredient)
6.2. Global Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Captive Manufacturers
Merchant Manufacturers
6.3. Global Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Drugs
Over-The-Counter Drugs
6.4. Global Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Communicable Diseases
Oncology
Diabetes
Cardiovascular Disease
Pain Management
Respiratory Diseases
Other Therapeutic Applications

7. Active Pharmaceutical Ingredients Market Regional And Country Analysis

7.1. Global Active Pharmaceutical Ingredients Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Active Pharmaceutical Ingredients Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Active Pharmaceutical Ingredients Market

8.1. Asia-Pacific Active Pharmaceutical Ingredients Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Active Pharmaceutical Ingredients Market

9.1. China Active Pharmaceutical Ingredients Market Overview
9.2. China Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Active Pharmaceutical Ingredients Market

10.1. India Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Active Pharmaceutical Ingredients Market

11.1. Japan Active Pharmaceutical Ingredients Market Overview
11.2. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Active Pharmaceutical Ingredients Market

12.1. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Active Pharmaceutical Ingredients Market

13.1. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Active Pharmaceutical Ingredients Market

14.1. South Korea Active Pharmaceutical Ingredients Market Overview
14.2. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Active Pharmaceutical Ingredients Market

15.1. Western Europe Active Pharmaceutical Ingredients Market Overview
15.2. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Active Pharmaceutical Ingredients Market

16.1. UK Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Active Pharmaceutical Ingredients Market

17.1. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Active Pharmaceutical Ingredients Market

18.1. France Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Active Pharmaceutical Ingredients Market

19.1. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Active Pharmaceutical Ingredients Market

20.1. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Active Pharmaceutical Ingredients Market

21.1. Eastern Europe Active Pharmaceutical Ingredients Market Overview
21.2. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Active Pharmaceutical Ingredients Market

22.1. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Active Pharmaceutical Ingredients Market

23.1. North America Active Pharmaceutical Ingredients Market Overview
23.2. North America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Active Pharmaceutical Ingredients Market

24.1. USA Active Pharmaceutical Ingredients Market Overview
24.2. USA Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Active Pharmaceutical Ingredients Market

25.1. Canada Active Pharmaceutical Ingredients Market Overview
25.2. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Active Pharmaceutical Ingredients Market

26.1. South America Active Pharmaceutical Ingredients Market Overview
26.2. South America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Active Pharmaceutical Ingredients Market

27.1. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Active Pharmaceutical Ingredients Market

28.1. Middle East Active Pharmaceutical Ingredients Market Overview
28.2. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Active Pharmaceutical Ingredients Market

29.1. Africa Active Pharmaceutical Ingredients Market Overview
29.2. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Active Pharmaceutical Ingredients Market Competitive Landscape And Company Profiles

30.1. Active Pharmaceutical Ingredients Market Competitive Landscape
30.2. Active Pharmaceutical Ingredients Market Company Profiles
- 30.2.1. Albemarle Corporation
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Aurobindo Pharma Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Dr. Reddy's Laboratories Limited
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Teva Pharmaceutical Industries Limited
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Active Pharmaceutical Ingredients Market Competitive Benchmarking

32. Global Active Pharmaceutical Ingredients Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients Market

34. Active Pharmaceutical Ingredients Market Future Outlook and Potential Analysis

34.1 Active Pharmaceutical Ingredients Market In 2028 - Countries Offering Most New Opportunities
34.2 Active Pharmaceutical Ingredients Market In 2028 - Segments Offering Most New Opportunities
34.3 Active Pharmaceutical Ingredients Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer